Updated: Apr 17, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Mohamed Salem1, Bradley A Gross2, Rose Du2
1Department of Neurological Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
In 2014, studies on cerebrovascular disease management revealed no benefit of simvastatin for subarachnoid hemorrhage and mixed results for brain arteriovenous malformations. Familial screening and new endovascular techniques show promise for aneurysm and AVM treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: